
Sign up to save your podcasts
Or
Dr. Rajesh Chowdhary Ph.D., CEO of Pharmacogenomics LLC and CSO of Insilicom LLC from the United States participated in Risk Roundup to discuss The Rise of Gene Editing. The Rise of Gene Editing Today, technologies like CRISPR allow genetic material to be inserted, deleted, modified, or replaced in any living biological species. As gene editing tools become efficient […]
The post The Rise Of Gene Editing appeared first on Risk Group.
4
44 ratings
Dr. Rajesh Chowdhary Ph.D., CEO of Pharmacogenomics LLC and CSO of Insilicom LLC from the United States participated in Risk Roundup to discuss The Rise of Gene Editing. The Rise of Gene Editing Today, technologies like CRISPR allow genetic material to be inserted, deleted, modified, or replaced in any living biological species. As gene editing tools become efficient […]
The post The Rise Of Gene Editing appeared first on Risk Group.